The AcrySof IQ Vivity from Alcon Inc. - presbyopia lens for everyday sharpness

The AcrySof IQ Vivity extends depth of focus so cataract patients see more clearly at multiple distances with fewer halos than classic multifocal lenses. This bestseller stays in focus for holders of Alcon shares (ISIN CH0432492467).

Reviewed: ad hoc news B2B & Pro desk. Edited and checked on 2026-06-27, 07:53. Details in the imprint.

In the operating room, the AcrySof IQ Vivity lens from Alcon Inc. looks almost understated, a clear oval disc balanced on the tip of the surgeon's gloved finger before sliding into place behind the pupil. Once implanted, patients often describe that first clinic corridor walk home as quietly convincing, with signs, faces and door numbers snapping into cleaner focus than the cloudy world they left behind.

What the Vivity lens does

The AcrySof IQ Vivity is an extended depth-of-focus intraocular lens designed for cataract patients who also struggle with presbyopia, the age-related loss of near vision. Instead of splitting light into distinct focal points like many multifocal designs, Vivity stretches the focus range to keep more of the scene in acceptable sharpness at once.

That optical trick aims to deliver functional distance and intermediate vision while keeping photic phenomena such as halos and glare at bay. Ophthalmologist feedback in early clinical use has been quietly positive, noting that patients often adapt quickly because the visual experience feels closer to a smooth, continuous focus curve than to the segmented sensation of classic multifocal lenses.

How it feels in daily life

For the wearer, the technology matters less than the mundane details: reading the bus number at twilight, spotting the correct bottle on a bathroom shelf, checking a phone screen without fumbling for readers. Many Vivity recipients report that these intermediate-distance chores become noticeably easier, even if they still reach for glasses for very fine print under dim light.

One cataract specialist, Dr. Elena Martínez, describes the outcome to her patients as “a broader plateau of comfortable vision rather than a steep peak”, a phrase that resonates when they later notice they can cook, watch TV and chat across the table without switching spectacles every few minutes. Her experience also underscores that expectation management remains central, because no lens erases every compromise.

Design choices and trade-offs

Vivity uses a non-diffractive surface profile to manipulate how light passes through the lens, seeking a balanced focus range without creating strong secondary images. In practice, that design tends to favor distance and intermediate clarity, while near reading performance depends heavily on individual anatomy and lighting.

Surgeons therefore position Vivity as a practical compromise: a lens for patients who want more freedom from glasses in everyday tasks but are willing to accept that absolute fine-near work may still benefit from eyewear. That framing is crucial, because mismatched expectations are often what turns a clinically solid result into a sobering patient story.

Where it sits in Alcon's line-up

Within Alcon's broad cataract portfolio, AcrySof IQ Vivity occupies the extended depth-of-focus segment alongside traditional monofocal and multifocal options. It is targeted at those who find classic multifocal lenses too raw in terms of halos but still want more flexibility than a pure monofocal can offer.

Product managers at Alcon like to point out that Vivity sits on the familiar AcrySof platform, a long-running lens material and design family with millions of implants worldwide. For surgeons, that continuity helps because handling, incision size and delivery systems feel consistent, reducing the learning curve in already time-pressured operating lists.

Practicalities for clinics

From a hospital perspective, Vivity is a premium lens choice, usually sitting above standard reimbursed monofocal options and often offered as a self-pay upgrade in many markets. That pricing reflects both the optical engineering and the market positioning in the presbyopia-correcting space.

Clinic administrators weigh those costs against patient satisfaction and word-of-mouth. Cataract surgery is one of the most common procedures worldwide, and a lens that leaves people able to drive, shop and work at a screen with less hassle tends to generate the kind of quiet loyalty that shows up in referral patterns over time.

Stock and company context

Alcon, headquartered in Switzerland, lists its shares on the SIX Swiss Exchange under ISIN CH0432492467. The Alcon share price trades in Swiss francs, and cataract lenses like AcrySof IQ Vivity form a core part of the company’s surgical segment that investors watch closely.

Key facts on AcrySof IQ Vivity

• Product: AcrySof IQ Vivity
• Manufacturer: Alcon Inc., a division of Alcon AG
• Category: B2B & Pro - intraocular lens for cataract and presbyopia correction
• Launch: Marketed internationally in the early 2020s, rollout varying by country
• RRP / Price: Premium-priced surgical lens, typically billed via clinic packages rather than retail; final patient costs depend on national reimbursement and provider
• Availability: Available through ophthalmic surgeons and hospitals using Alcon’s cataract portfolio; not sold directly to consumers
• Target group: Cataract patients seeking improved distance and intermediate vision with reduced reliance on glasses
• Highlight / USP: Extended depth-of-focus optical design that aims to balance range of vision with a low rate of halos and glare.

Note: AcrySof IQ Vivity is a surgical device distributed to clinics, not a consumer product on amazon.de, so there is no Amazon listing for retail purchase.

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.